The latest report by IMARC Group, titled “Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market. The global clinical nutrition market size reached US$ 51.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 101.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Factors Affecting the Growth of the Clinical Nutrition Industry:
- Increasing Geriatric Population:
The global demographic shift toward an increasing geriatric population has significant implications for healthcare, particularly in the realm of clinical nutrition. Additionally, older adults often experience a range of chronic conditions that necessitate specific nutritional interventions to manage symptoms and enhance quality of life. For instance, age-related decreases in bone density and muscle mass can be mitigated with targeted nutritional support. Moreover, clinical nutrition also plays a critical role in recovery processes, as adequate nutrition can significantly impact the healing rates and overall health of elderly patients. As a result, the demand for specialized clinical nutrition products designed to meet the unique dietary needs of the aging population is prompting healthcare providers to focus more on customized nutritional care plans across the globe.
- Rising Prevalence of Chronic Diseases:
The global rise in chronic diseases such as diabetes, obesity, cardiovascular diseases, and cancer is escalating the demand for clinical nutrition products. These conditions often require long-term dietary adjustments to manage and mitigate associated health risks. Additionally, clinical nutritionists are integral in developing and administering specialized diets that cater to the specific needs of individuals affected by these conditions. For instance, heart-healthy diets that are low in sodium and fat are essential for patients with cardiovascular diseases, while balanced nutrient-rich diets are essential for cancer patients undergoing chemotherapy. Hence, the growing number of diseases underscores the need for comprehensive nutritional strategies that can improve patient outcomes and reduce the burden of these diseases on healthcare systems.
- Medical Technology Advancements:
Recent advancements in medical technology have greatly expanded the capabilities of clinical nutrition, making it possible to tailor nutritional interventions to individual patient needs more effectively. Moreover, several innovations in medical diagnostics, such as more precise biomarker tests, allow for a better understanding of an individual’s specific nutritional deficiencies and how they might affect overall health and recovery from illness. Additionally, several advancements in treatment technologies facilitate the integration of nutritional therapy with medical treatments, enhancing the efficacy of both. For instance, personalized nutrition plans based on genetic profiles can now be developed to optimize health outcomes, demonstrating how technology is enabling more nuanced and effective approaches to nutrition in clinical settings across the globe.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/clinical-nutrition-market/requestsample
Competitive Landscape:
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Braun Melsungen AG
- BASF SE
- Baxter International Inc.
- Danone S.A.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Koninklijke DSM N.V.
- Meiji Holdings Co. Ltd.
- Nestlé S.A.
- Perrigo Company plc
- Reckitt Benckiser Group PLC
Clinical Nutrition Market Report Segmentation:
By Product:
- Infant Nutrition
- Parental Nutrition
- Enteral Nutrition
Infant nutrition represents the largest segment due to the rising demand for specialized formulas catering to infants’ nutritional needs during early growth stages.
By Route Of Administration:
- Oral
- Enteral
- Parenteral
Oral holds the largest market share as it is the most common and convenient method for administering nutritional supplements and medications.
By Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
On the basis of the application, the market has been classified into cancer, malnutrition, metabolic disorders, gastrointestinal disorders, neurological disorders, and others.
By End User:
- Pediatric
- Adults
- Geriatric
Pediatrics accounts for the largest market share as children require specific nutritional formulations tailored to their developmental needs and health conditions.
Regional Insight:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Asia Pacific’s dominance in the clinical nutrition market is attributed to increasing population, rising disposable income, and growing awareness about nutrition and health among consumers in the region.
Global Clinical Nutrition Market Trends:
There is a growing trend toward personalized nutrition plans tailored to individual health needs, genetic predispositions, and lifestyle factors. This trend includes the development of specialized clinical nutrition products that cater to specific patient profiles. Additionally, the increasing consumer preference for natural and organic ingredients has led to the development of plant-based clinical nutrition products. These products cater to vegetarian, vegan, and environmentally conscious consumers. Moreover, the COVID-19 pandemic has raised awareness of immune health, leading to a surge in demand for clinical nutrition products that support immune function. This trend includes products fortified with vitamins, minerals, and antioxidants.
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Our Other Reports:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
